| Similar Articles |
|---|
 |
Bio-IT World
February 18, 2004 |
A Guide to GeneMatcher Paracel's vice president of product management Joseph Borkowski explains the history and attributes of GeneMatcher, the company's massively parallel supercomputer designed to enhance bioinformatics algorithms, to editor-in-chief Kevin Davies.   |
Bio-IT World
February 2006
Kevin Davies |
Celera Drops Drugs for Diagnostics The company that raced to sequence the human genome, ditched its flamboyant CEO and database subscription model to become a drug development company, has decided to change course yet again. |
Bio-IT World
November 19, 2004
Salvatore Salamone |
Accelerator Market: Not Dead Yet Cray, Fujitsu, and Timelogic are just a few of the hardware companies hoping to fill the void left by the sudden recent demise of Paracel. They all offer products designed to accelerate scientific computations. |
Bio-IT World
July 15, 2003
Salvatore Salamone |
Buying Power Celera's decision to replace its Compaq supercomputer with IBM and EMC is surprising. It also provides a fascinating how to procurement model for the bio-IT industry. |
Bio-IT World
March 17, 2004 |
Genome War and Peace The belated result is a fluid and frequently compelling book, with some fascinating insights into the commercial and political wrangling that accompanied the creation of Celera and ultimately undermined Venter's goal of becoming the Bloomberg of genomics. |
Bio-IT World
November 12, 2002
Davies et al. |
John Craig Venter Unvarnished The former Celera CEO talks about that company's politics, the future of sequencing technology, and his own genome. |
Bio-IT World
June 2005
Maureen McDonough |
Celera Releases Genome Data In a decision that essentially marks the end of the genome wars, Celera Genomics will release its formerly proprietary human, mouse, and rat genome sequences to the public domain. |
Fast Company
September 2000
John Ellis |
The Secret of Life The mapping of the human genome, says Craig Venter, will change science, research, medicine, politics, health insurance, and the way biology looks at the last 3 billion years of evolution. And that's just the beginning. |
The Motley Fool
December 30, 2008
Brian Orelli |
A Post-Holiday Breakup ... of Sorts Abbott and Celera revise their partnership. |
Bio-IT World
June 2005
John Russell |
A Totally Spooky Evening Paul Mullin's wonderful play, The Sequence, spills out the sometimes sordid details of the rivalry between the two men who were at the heads of the institutions racing to sequence the human genome. |
BusinessWeek
December 13, 2004
John Carey |
Craig Venter: DNA's Mapmaker Who could ever have imagined that a surfer working as a night clerk at Sears, Roebuck & Co. would eventually become the driving force behind the race to read the genetic code of humanity? |
